“…33 Previous evidence has shown that in renal patients on hemodialysis treatment enhanced oxidative-inflammatory stress may be associated with iron load and this may contribute to iron functional deficiency by making it difficult to attain the target hematocrit. [4][5][6][34][35][36][37][38] However, the lowest level of ferritin to maintain control of anemia without inducing oxidative tissue damage and increasing the risk of infections and cardiovascular diseases is still unknown. 38 Senol et al 39 found that 34 well-nourished HD patients had higher hsCRP and lipid peroxidation products (red blood cell malondialdehyde) when compared with 22 healthy controls.…”
“…33 Previous evidence has shown that in renal patients on hemodialysis treatment enhanced oxidative-inflammatory stress may be associated with iron load and this may contribute to iron functional deficiency by making it difficult to attain the target hematocrit. [4][5][6][34][35][36][37][38] However, the lowest level of ferritin to maintain control of anemia without inducing oxidative tissue damage and increasing the risk of infections and cardiovascular diseases is still unknown. 38 Senol et al 39 found that 34 well-nourished HD patients had higher hsCRP and lipid peroxidation products (red blood cell malondialdehyde) when compared with 22 healthy controls.…”
There are no acute deteriorating effects from a 100 mg of intravenous iron-sucrose in CAPD patients with optimal iron stores. This dose may be applied safely in CAPD patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.